Mechanistic studies revealed that RN181 controls tumour growth through induction of cell cycle arrest at the G1–S phase transition by inhibition of ERK/MAPK signalling and thereby regulation of the cyclin D1–CDK4 activity in GC. This evidence concerns the gene CDK4 and neoplasm.